PDUFA V Commitment Letter Front-Loads Guidance, Meeting Milestones

It may not feel like it to exhausted user fee negotiators, but the release of FDA’s draft commitment letter for PDUFA V signals the start of more long campaigns for the agency and pharmaceutical companies.

More from Archive

More from Pink Sheet